The Potential Tumor Promotional Role of circVAPA in Retinoblastoma via Regulating miR-615-3p and SMARCE1 [Retraction]
Xu Q. Onco Targets Ther. 2020;13:7839–7849.
At the request of the author, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article.
The author contacted the journal after realising the Y79 cells had been mixed up with HEK-293T cells following a labelling error and the wrong results had been reported for the Y79 cell line. The author was unable to provide satisfactory raw data for the western blots shown in Figure 5F and was also unable to provide the original images shown in Figure 6A.
The editor determined the findings of the article were no longer valid and agreed with the authors request to retract the article.
The author wishes to apologise for this error.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]